From 5% to 10% of malignant tumors involving the ovary are metastatic 1 and frequently are mistaken for primary ovarian carcinomas. 2 The distinction of metastatic ovarian carcinoma from a primary malignant ovarian neoplasm is crucial to its subsequent management, 3 and diagnostic misinterpretation may have important adverse consequences for the patient. 4 Most ovarian metastases arise from the gastrointestinal tract, and colonic adenocarcinomas account for 37% to 45% of all metastatic ovarian tumors. 5 Metastatic colonic carcinomas may simulate endometrioid carcinomas or mucinous carcinomas on gross and histologic examination.
From 5% to 10% of malignant tumors involving the ovary are metastatic 1 and frequently are mistaken for primary ovarian carcinomas. 2 The distinction of metastatic ovarian carcinoma from a primary malignant ovarian neoplasm is crucial to its subsequent management, 3 and diagnostic misinterpretation may have important adverse consequences for the patient. 4 Most ovarian metastases arise from the gastrointestinal tract, and colonic adenocarcinomas account for 37% to 45% of all metastatic ovarian tumors. 5 Metastatic colonic carcinomas may simulate endometrioid carcinomas or mucinous carcinomas on gross and histologic examination.
Previous studies have suggested morphologic and immunohistochemical distinguishing criteria. The identification of a specific subtype of necrosis, the so-called dirty necrosis, in conjunction with a garland or cribriform pattern of tumor glands has been suggested as a useful histologic feature to identify colonic carcinomas metastatic to the ovary. 3 Among tumor markers, CA125 is known to be an important indicator of ovarian carcinomas in tumor cells 6 and in the serum, 7 but it is absent in mucinous tumors. 7 Carcinoembryonic antigen is often positive in colorectal carcinomas, 5 whereas endometrioid carcinomas of the ovary are less commonly positive for carcinoembryonic antigen. 8 Subgroups of cytokeratins (CKs) also have been used to differentiate primary from metastatic carcinomas. CK7 has been shown to be ubiquitously present in primary ovarian carcinomas but not in colorectal carcinomas. 9 In contrast, CK20 is well expressed in colorectal carcinomas and their metastases, but it usually is absent in primary ovarian carcinomas. 10, 11 As far as we know, no studies are reported in the literature that deal with the cytogenetic characteristics of metastatic ovarian neoplasms. The purpose of the present study was to identify and clarify some possible morphologic, immunohistochemical, and cytogenetic criteria helpful for differentiating primary ovarian carcinomas and ovarian metastases from colorectal carcinomas.
Materials and Methods

Clinicopathologic and Immunohistochemical Studies
We studied 23 ovarian metastases from colorectal carcinomas and, for comparison, 23 primary ovarian carcinomas, including 16 mucinous carcinomas and 7 endometrioid carcinomas. The cases were obtained from the surgical pathology files of the Department of Clinical and Biological Sciences, University of Insubria, Varese, Italy. Clinicopathologic information about patient age, tumor site and size, evidence of local invasion, and signs of recurrence or distant metastases was obtained from patient records or by contacting clinicians. The gross appearance of the involved ovaries was recorded.
Formalin-fixed paraffin-embedded sections of the tissues were stained routinely with H&E. Microscopic slides of all 46 cases were reviewed, and the following histologic parameters were analyzed: histologic type, grade, mitotic index, cytologic atypia, and type and extent of necrosis. Primary ovarian carcinomas were classified histologically according to the 1995 International Federation of Gynecology and Obstetrics criteria, whereas the metastases were classified into different patterns according to Young and Scully. 1 To assess the mitotic index, at least 10 microscopic fields in each case were examined under high power (×400), and the number of mitoses per 10 high-power fields (HPF) was counted. Nuclear atypia was scored as follows: mild (+), almost all nuclei were regular; moderate (++), nuclei showed cytologic features intermediate between mild and severe; or severe (+++), nuclei were markedly hyperchromatic and irregular in size. Dirty necrosis (scarce, 1+; moderate, 2+; abundant, 3+) was defined as the presence of eosinophilic and coarsely granular necrotic material containing abundant karyorrhectic debris 5 and exhibiting several patterns (intraluminal, segmental, and confluent). The presence of garland formation and cribriform pattern was noted.
A panel of immunohistochemical stains was applied to all cases. Paraffin sections were deparaffinized, hydrated in a graded alcohol series, quenched with 3% hydrogen peroxide for 10 minutes, and incubated with primary antibodies ❚Table 1❚ at 4°C for 18 to 20 hours, followed by the avidin-biotin complex procedure according to Hsu et al. 12 Sections stained for CA125 were pretreated for 10 minutes with 0.003% subtilisin (protease type XXVII or Nagarse protease, P4789, Sigma, St Louis, MO) in a 0.05-mol/L concentration of tris(hydroxymethyl)aminomethane (Tris)-buffered saline, pH 7.4. Sections stained for M1 were pretreated with 0.05% trypsin in a 0.05-mol/L concentration of Tris-buffered saline, pH 7.4, for 20 minutes. Finally, paraffin sections for estrogen receptors, progesterone receptors, CK7, 10 CK20, and alpha-inhibin 13 were pretreated for 10 minutes with a 0.01-mol/L concentration of citrate buffer, pH 6.0, in a microwave oven at 650 W. Specificity controls included omission of the first layer and use of control tissues with or without the pertinent antigen. Immunoreactivity was evaluated semiquantitatively as the percentage of positive cells. Only tumors with more than 5% of immunoreactive cells were considered positive to the antibodies tested.
Cytogenetic and Fluorescence In Situ Hybridization Analysis
We obtained only 5 fresh samples from 34 samples of ovarian metastases (2 samples were bilateral metastases from the same patient) and 18 fresh samples of primary colorectal carcinoma after surgical removal under sterile conditions. In the remaining 29 samples of ovarian metastases, only material fixed in formalin was obtained, and as a result direct preparations could not be made. The tumor karyotype was determined on direct preparations as described by Tibiletti et al. 14, 15 Briefly the suspension of small pieces obtained by mincing the tumor was incubated for 48 or 72 hours at 37°C with 5% carbon dioxide and harvested after overnight treatment with colchicin (Colcemid, Celbio, Milan, Italy) (0.02 µg/mL). Karyotype evaluation was performed using Q and G banding techniques. Chromosome abnormalities were described according to the Cancer Cytogenetic Supplement recommendations. 16 In particular, only clonal abnormalities were considered in the description of the tumor karyotype; more specifically, the same structural rearrangement or chromosomal gain had to be present in at least 2 metaphases, whereas loss of a chromosome had to be detected in at least 3 metaphases. When different tumor cell populations were identified, the chromosome complement of each population was described. A diploid cell line was defined when the chromosome number ranged from 35 to 57, while a triploid cell line was defined when the chromosome number ranged from 58 to 80.
Fluorescence in situ hybridization (FISH) using whole chromosome painting for chromosomes 1, 3, 6, 13, and 14 (painting for chromosomes, Cambio, Cambridge, England) was performed following the method of Pinkel et al 17 with modifications. The chromosomal DNA was denatured in 70% formamide, 2× standard saline citrate (SSC; pH 7.0) at 72°C for 2 minutes. Painting DNA probes were denatured at 65°C for 10 minutes and preannealed for 1 hour at 37°C. Hybridization was done at 42°C overnight in a humid chamber. Washes were performed twice at 42°C for 10 minutes in 50% formamide/2× SSC and 3 times for 5 minutes in 2× SSC at 42°C. Hybridized probes were detected by using a fluorescein-avidin detection kit (Oncor, Gaithersburg, MD). Preparations were mounted in antifade solution containing propidium iodide (PI) or 4´-6-diamino-2-phenylindole (DAPI) and observed with a fluorescence microscope (Leica DMR, Leica, Wetzlar, Germany) under single-band fluorescein isothiocyanate or triple-band filters.
Statistical Analysis
Statistical significance of results was tested by using the Fisher exact test. A P value of less than .05 was interpreted as the meaningful criterion. The sensitivity and specificity for separating metastases from primary ovarian carcinomas were calculated for some immunohistochemical and for cytogenetic markers.
Results
Ovarian Metastases
Clinical Findings
The age of the patients ranged from 33 to 84 years (mean, 58 years) at the time of diagnosis of ovarian metastases. In 16 of 23 cases, the ovarian tumor and the large bowel carcinoma were discovered synchronously; 5 cases of ovarian metastases were metachronous; and in 1 case, ovarian metastasis represented the first manifestation of the disease. Of the primary intestinal carcinomas, 9 cases occurred in the rectosigmoid colon. The ascending and descending colon were involved with a similar frequency (8 and 5 cases, respectively). In 18 patients, lymph nodal (14 cases), omental (6 cases), hepatic (4 cases), small intestinal (1 case), dermal (1 case), and uterine (1 case) metastases also were present. In 3 cases, information was not available.
Pathologic Findings
Gross Features.-Secondary ovarian neoplasms ranged in size from 1 to 22 cm (median, 10.5 cm) in greatest dimension. Gross examination revealed that 10 tumors were solid while 12 were predominantly cystic, closely simulating primary ovarian carcinomas. Bilaterality was present in 11 of 23 cases. Unilateral metastasis was more frequent in the right ovary.
Microscopic Features.-Histologic examination ❚Table 2❚ revealed that 16 of 34 ovarian metastases were classified, according to the method of Young and Scully, 1 as pseudoendometrioid, 16 as mucinous, and 2 as mixed. All cases showed a prevalent garland pattern with cystic glandular structures containing necrotic debris ❚Image 1❚. In cystic spaces, papillary projections and cribriform aspects were present. Glandular lining often was interrupted by segmental and confluent intraluminal necrosis, sometimes so prominent that it obscured the majority of the tumor. A peculiar feature was the presence of dirty necrosis, which was noted in 15 of the 16 pseudoendometrioid metastases and in 13 of 16 mucinous metastases with a variable degree of extent (1+, 2+, or 3+). Mucinous neoplasms showed abundant extracellular mucus.
The glands were lined by stratified, tall, columnar, absorptive-like cells intermingled with a variable proportion of goblet cells. The hyperchromatic nuclei appeared cigar-shaped or rounded and were oriented basally. Cytologic atypia was prominent (2+ or 3+) in 24 of the 34 ovarian metastases ❚Image 2❚. Mitoses were abundant in all evaluated cases. In particular, pseudoendometrioid and mucinous metastases displayed a very high mitotic index (range, 5-116; median, 34 per 10 HPFs), including bizarre and haphazard mitotic features even in the architecturally well-differentiated areas. Besides the obvious cytologically malignant mucinous epithelium, 8 cases showed areas composed of a monostratified mucinous well-differentiated epithelium. None of the cases had areas of squamous differentiation. The stroma varied from negligible to abundant. It was desmoplastic in 22 of the cases, but sometimes it was edematous or mucoid. Stromal luteinization was observed focally in few cases.
Immunohistochemical Features
Our data ❚Table 3❚ showed that only 6 of 27 ovarian metastases tested contained extracellular and intracellular mucus immunoreactive for M1. In 19 ovarian metastases, few and scattered cathepsin E-staining cells were present along the luminal margins and the apical cytoplasm of the epithelia of the glands. In only 4 ovarian metastases a weak CA125 positivity was found in rare cells. Results for vimentin and estrogen and progesterone receptors were consistently negative in tumor cells. Metastatic tumors were strongly and diffusely positive for CK20 ❚Image 3❚ in all ovarian metastases tested; weak CK7 positivity was observed in 4 of 22 ovarian metastases. Positivity for alpha-inhibin was present in the stromal cells of metastatic tumors in 10 of the 17 ovarian metastases tested.
Cytogenetic and FISH Results
The tumor karyotypes of 5 samples of ovarian metastases from large bowel were defined ❚Table 4❚. Three samples showed 2 cell lines, 1 diploid and 1 triploid (cases 20a, 20b, and 22), while the other 2 samples showed only a triploid complement (cases 18 and 21). The abnormalities more often represented were chromosome markers, as shown in Table 4 . In particular, m1 and m2 were present in 4 of 5 samples. Gains and losses of different chromosomes were present in all cases, while chromosome rearrangements were less frequent and identified by FISH as a derivative of chromosome 1 (cases 18, 20a, and 20b), a derivative of chromosome 3 (cases 21 and 22) , and a derivative of chromosome 6 (case 20a). It is noteworthy that the 2 samples obtained from bilateral ovarian metastases showed similar chromosome anomalies: derivatives of 1p and 1q, gains and losses of the same chromosomes. For comparison, we also cytogenetically studied a series of primary colorectal carcinomas. The tumor karyotypes are listed in ❚Table 5❚. Interestingly, both primary colorectal carcinoma (case 6 in Table 5 ) and ovarian metastasis (case 21 in Table 4 ) were analyzed, and the same triploid complement, markers m1 and m2, ring chromosome, and gains and losses, were found. In summary, gains of chromosome 13 (trisomy or derivative) also were the more frequent anomaly observed in primary colorectal carcinomas.
Primary Ovarian Carcinomas
Clinical Features
Mucinous carcinomas occurred most frequently in patients who were between the ages of 24 and 87 years (median, 56 years), whereas the patients with endometrioid carcinomas ranged in age from 43 to 90 years (mean age, 64 years).
Pathologic Features
Gross Findings.-Mucinous carcinomas were grossly cystic, multiloculated neoplasms (7/16) ranging in diameter from 1 to 33 cm (median, 12.7 cm). Solid areas and papillary endocystic projections were frequent. Twelve of 14 mucinous neoplasms were unilateral. Four of 7 endometrioid carcinomas were cystic, ranging in size from 8 to 30 cm (median, 15 cm). Friable, soft, or papillary structures partly filled the lumen in 2 of 7 cases. All endometrioid carcinomas with available data were unilateral. Microscopic Findings.-Mucinous carcinomas (Table  2) showed glandular cystic features mixed with microglandular cribriform aspects. Tubular glands, sometimes ectatic, were lined by tall columnar mucin-producing cells, intermingled with goblet cells and absorptive-like cells; occasionally a few scattered endocrine cells were present. Mucous columnar cells displayed rounded vesicular nuclei. Atypia was generally mild or moderate. Mitoses ranged from few to numerous (range, 0-27 per 10 HPFs). Eight of 16 mucinous carcinomas showed benign and borderline histologic areas along with obvious stromal invasion. In 2/3 of our cases, we also found 2 patterns of necrosis: dirty and ischemic, but necrotic areas were usually only focal. Five of 16 mucinous carcinomas exhibited foci of stromal desmoplasia accompanied by broken glands and extracellular mucus. Examination of endometrioid carcinomas showed the prevalent presence of a mixed glandular-cystic and microglandular-solid architecture accompanied by irregular and crowded tubular glands. The epithelium displayed stratified and atypical endometrial-like cells with vesicular nuclei (4/7) and enlarged nucleoli. The mitotic index was high (range, 0-32; median, 17 per 10 HPFs). Limited foci of centroglandular dirty necrosis were found in 5 of 7 cases and of ischemic necrosis in 2 of 7 cases. In 6 of 7 endometrioid carcinomas, focal and/or diffuse stromal desmoplasia (2+ or 3+) was detected. Squamous metaplasia was detected in 5 of 7 cases of endometrioid carcinomas.
Immunohistochemical Features
M1 immunoreactivity (Table 3) was expressed frequently and abundantly in the intracellular and extracellular mucus of 12 of 16 mucinous carcinomas but rarely in endometrioid carcinomas (1/7). Cathepsin E was prominent in 10 of 14 ovarian mucinous carcinomas ❚Image 4❚, displaying a finely granular gastric foveolar-like positive cytoplasmic staining, whereas none of the 5 endometrioid carcinomas evaluated were positive for cathepsin E. All mucinous carcinomas examined were negative for CA125, vimentin, and estrogen and progesterone receptors. On the contrary, endometrioid carcinomas were positive for CA125 (4/7), estrogen receptor (2/7), and progesterone receptor (4/7) and 2 of 4 endometrioid carcinomas analyzed showed epithelial vimentin positivity. CK7 immunoreactivity was strongly and diffusely expressed in mucinous carcinomas (13/16) ❚Image 5❚ and endometrioid carcinomas (6/7). On the contrary, CK20 was rarely and poorly expressed in endometrioid carcinomas (1/7) and only focally observed in 13 of 16 mucinous carcinomas. Positivity for alpha-inhibin was present only in the stromal cells of 3 of 4 endometrioid and 3 of 4 mucinous carcinomas evaluated.
Cytogenetic Features
For the present study, we used the same technical approach as that used by Tibiletti et al 14, 15 for conventional cytogenetic and FISH analysis on 40 cases of primary ovarian carcinomas. In the present study, the cytogenetic pattern of primary ovarian carcinomas was different from that of the metastases ❚Image 6❚; particularly, trisomy of chromosome 13 was a rare finding (2 cases). The chromosome abnormality more frequently detected was 6q deletion. These cytogenetic results were confirmed using FISH techniques.
Statistical Analysis
The Fisher exact test revealed that among clinicopathologic features, bilaterality (P = .007) and dirty necrosis (P = .009) were criteria favoring metastases. CK7 negativity (P = .00001) and CK20 positivity (P = .0009) were the most significant immunohistochemical markers of metastases, while there were no significant differences regarding expression of cathepsin E and CA125 between metastases and primary ovarian carcinomas. Gains of chromosome 13 were significantly more frequent in colorectal carcinomas and in their ovarian metastases than in primary ovarian carcinomas (P = .0000008).
Among immunohistochemical markers of metastases, CK20 positivity showed a great degree of sensitivity (100%) but a very low specificity (39%), while CK7 negativity showed high specificity (83%) and sensitivity (82%). In addition, gains of chromosome 13 displayed high specificity (95%) and moderate sensitivity (77%).
Discussion
The ovary is a common site for spread of carcinomas from the gastrointestinal tract. Most of the literature on this subject has concentrated on metastatic signet-ring cell carcinomas of gastric origin (Krukenberg tumors). 5, 18, 19 Few studies have addressed the more common problem of accurate diagnosis of metastatic colonic adenocarcinoma. 5, 20 A thorough history facilitates the diagnosis, but occasionally, a complete clinical history is not available or the ovarian tumor may be the first indication of an unsuspected primary carcinoma of the colon.
Patients with intestinal adenocarcinoma metastatic to the ovary may be classified as follows: (1) those in whom an intestinal carcinoma precedes the detection of ovarian tumor (8 of 23 of our cases); (2) those in whom the ovarian involvement is detected synchronously at the time of operation for large bowel carcinoma (17 of 23 of our series), and (3) those with initial manifestations of an ovarian tumor (1 of 23 of our cases). 3, 21 The presence of extraovarian disease at certain sites merits consideration by the surgeon and pathologist in distinguishing between primary and metastatic ovarian tumor. Omental, hepatic parenchymal metastases, a prominent involvement of the peritoneal surface and/or of mesenteric lymph nodes (18 of 20 of our cases) favor an intestinal primary site. Our present findings confirm that extrapelvic spread is a helpful feature in the distinction of ovarian metastasis from colon carcinoma. Bilaterality favors a metastatic tumor; although bilaterality is a feature of many primary ovarian carcinomas, it occurs with much greater frequency (11 of 23 of our cases) in metastatic neoplasms with a statistically significant difference (P = .007).
Colonic metastases to the ovary often produce cystic or partly cystic tumors that may grossly simulate primary epithelial ovarian carcinoma. Histologic differentiation between colonic adenocarcinoma and ovarian carcinomas of the mucinous and endometrioid types may be particularly difficult. Because of the tumors' capability to reproduce different morphologic patterns, Young and Scully 1 introduced a classification of histologic aspects of metastatic ovarian carcinomas. They observed a prevalence of the glandular endometrioid-like pattern and of the mucinous-like pattern. We had similar findings in our series of metastatic colonic cancers that equally mimicked endometrioid carcinomas and mucinous carcinomas. According to Lash and Hart 5 and Daya et al, 3 the key to recognizing metastatic colonic adenocarcinoma and its distinction from primary ovarian carcinoma lies in its characteristic histologic appearance. Those studies showed that metastatic tumors almost always contain prominent garland and cribriform structures with intraluminal dirty necrosis, often accompanied by aggregates of rounded glands with segmental necrosis of their walls.
These criteria seemed easy to apply and useful, because all but 2 of 23 patients with metastatic colonic carcinomas showed an abundant dirty necrosis, with the presence of eosinophilic and coarsely granular necrotic material containing karyorrhectic debris and exhibiting several different patterns (intraluminal, segmental, and confluent), and the formation of garland or cribriform gland aspects. On the contrary, in our cases of primary ovarian carcinomas, mainly of the endometrioid type, dirty necrosis was not always present; in addition, it was very focal and of mild extent. The significance of this parameter has been confirmed by statistical analysis (P = .0009).
Classic cytologic criteria, such as the marked cytologic atypia (2+ or 3+) and the high mitotic index may be considered helpful in the definition of a correct diagnosis of ovarian metastases. In addition, in metastatic endometrioid-like tumors, absence of squamous metaplasia is a distinguishing feature from endometrioid carcinomas. Mucinous-like tumors can mimic mucinous carcinomas because of the presence of bland pseudobenign areas.
Our immunohistochemical results indicated that gastric M1 antigen and cathepsin E were expressed in primary and metastatic ovarian tumors. In the ovarian metastases, their immunoreactivity was only focal and limited to scattered cells, while primary ovarian carcinomas, especially mucinous, showed a prominent and diffuse M1 and cathepsin E positivity, which was often coexpressed in the same tumor areas, mimicking the distribution of these antigens in epithelial gastric foveolar cells. This pattern has been described by Tenti et al. 22 This different distribution and cathepsin E negativity of endometrioid carcinomas can help differentiate ovarian metastases from primary ovarian carcinomas.
The lack of CA125 was not surprising in ovarian metastases of colonic carcinomas, because this antigen generally is absent in tumors arising in extragynecologic sites. As expected, CK7 was expressed especially in mucinous carcinomas and endometrioid primary carcinomas, whereas it was rarely and scarcely present in colonic metastases (P = .00001). On the contrary, CK7 negativity was a highly sensitive and specific marker of colonic metastases, and the phenotype CK7-negative and CK20-positive was expressed in most of the metastatic colonic neoplasms that we examined, in agreement with the previous findings. 11, 23 Vimentin can be useful for the differential diagnosis, since it was present in 2 of 4 endometrioid primary ovarian carcinomas, but it was never found in our cases of ovarian metastases. On the basis of our immunohistochemical findings, we suggest that immunoreactivity for CK20 and lack of CA125, CK7, and vimentin favor the diagnosis of ovarian metastases from colonic carcinoma.
Stroma of colonic ovarian metastases expressed some alpha-inhibin-positive cells showing the same immunoreactivity pattern observed in primary ovarian carcinomas, especially the mucinous type. This result seems to be of great biologic interest, suggesting that sometimes the tumor stroma can retain phenotypic features of implantation tissue.
The conventional and molecular cytogenetic investigations of ovarian metastases from colorectal carcinomas indicate that gain of chromosome 13, as a trisomy or as a derivative from a translocation, is a peculiar feature of these neoplasms and of primary colon carcinomas. Gain of chromosome 13, as shown by our data and reported in the literature, characterized more than 50% of primary colorectal carcinomas, 16 but it was almost never identified in primary ovarian carcinomas 22, 24 (P = .0000008). Korn et al 25 and Meijer et al, 26 studying chromosome changes in liver metastases from colorectal carcinomas, identified gain of 13q as one of the more important findings. Our data suggest that gain of chromosome 13 may be a sensitive and specific feature in the identification of the origin of metastatic ovarian tumors. On this basis, cytogenetic studies or FISH analysis on interphasic nuclei with probes specific for chromosome 13 may be helpful for the diagnosis. The differentiating criteria and markers for a relatively simple approach are summarized in ❚Table 6❚. We hope that the application of the integration of clinicopathologic, immunohistochemical, and cytogenetic features described in this article for the study of ovarian metastases of colonic origin will make possible the development of useful guidelines for the diagnosis of such tumors.
